These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Effect of theophylline-ethylenediamine in obstructive lung disease (author's transl)].
    Author: Brossmann D, Ruf G, Wiessmann KJ.
    Journal: Dtsch Med Wochenschr; 1980 Mar 21; 105(12):410-3. PubMed ID: 7363785.
    Abstract:
    In 12 patients with obstructive respiratory tract disease there occurred a decrease in the mean respiratory tract resistance of maximally 37% and a fall in pulmonary artery pressure of maximally 28% six hours after oral administration of 700 mg theophylline-ethylenediamine (Aminophyllin retard). The effect lasted beyond the 12 hours of observation on the first day and, after 14-day administration of twice daily 350 mg, remained nearly unchanged. After two weeks there was a clinically significant increase in vital capacity averaging 13%, the residual volume decreased by 14%.
    [Abstract] [Full Text] [Related] [New Search]